1. < Prostate Cancer
Profile picture for surftohealth88

ASCO: GLP-1 Receptor Agonist Initiation Cuts Metastatic Progression

Posted by surftohealth88 @surftohealth88, 4 hours ago

https://www.renalandurologynews.com/reports/asco-glp-1-receptor-agonist-initiation-cuts-metastatic-progression-across-cancer-types/
This was talked about for couple of years now and it seems that hypothesis proved to be correct.

Interested in more discussions like this? Go to the Prostate Cancer Support Group.

Profile picture for Jeff Marchi
Jeff Marchi | @jeffmarc | 2 hours ago

Here are some articles that actually mentioned prostate cancer and GLP-1. Mostly in relation to Having fewer people get prostate cancer and fewer metastasis.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11479428/
ASCO highlighted four studies — some of which were published in its affiliated Journal of Clinical Oncology. The most prominent among them tracked medical and prescription records of over 10,000 patients with early-stage cancer, and found GLP-1s reduced cancer risk in 6 out of 7 cancers — four of them at statistically significant levels. Breast, liver, colorectal and non-small cell lung cancer risks declined significantly; kidney and prostate declined somewhat; pancreatic cancer rates were affected the least.
https://www.asco.org/about-asco/press-center/glp-may-reduce-metastatic-progression

REPLY
1 reply
Profile picture for surftohealth88
surftohealth88 | @surftohealth88 | 1 hour ago
In reply to @jeffmarc "Here are some articles that actually mentioned prostate cancer and GLP-1. Mostly in relation to Having..." + (show)
Profile picture for Jeff Marchi @jeffmarc

Here are some articles that actually mentioned prostate cancer and GLP-1. Mostly in relation to Having fewer people get prostate cancer and fewer metastasis.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11479428/
ASCO highlighted four studies — some of which were published in its affiliated Journal of Clinical Oncology. The most prominent among them tracked medical and prescription records of over 10,000 patients with early-stage cancer, and found GLP-1s reduced cancer risk in 6 out of 7 cancers — four of them at statistically significant levels. Breast, liver, colorectal and non-small cell lung cancer risks declined significantly; kidney and prostate declined somewhat; pancreatic cancer rates were affected the least.
https://www.asco.org/about-asco/press-center/glp-may-reduce-metastatic-progression

Jump to this post

@jeffmarc

Yes, it applies to PC also , that is why I posted it : ))). 👍 I am terribly busy today so did not have time to type additional info and links , I apologize and thanks for pointing it out so that other know why it is posted here 💗.

PS: How are you doing today : ))) ?! I hope that progress is fast and pain much less prominent. 🍀

REPLY
Please sign in or register to post a reply.